Home Events Events 2007

Events 2007

Events 2007

[ November 2007 ]
56th American Society of Tropical Medicine and Hygiene
(ASTMH) - Philadelphia, USA
/ DNDi's Symposium on ACT
Sanofi-aventis and DNDi held a symposium about the implementation of a new artemisinin
combination therapy (ACT) in African endemic countries. Over 120 attendees from NGOs,
academia, and the pharmaceutical sector were an audience to FACT project partners’
presentations on ASAQ and ASMQ. Besides that, DNDi also presented on the ethical
considerations of malaria field studies, and on the screening of natural products against
infectious disease pathogens.

More

 
[ September 2007 ]
Scientific Symposium on Visceral Leishmaniasis (VL) - London

DNDi and the Leishmaniasis East Africa Platform (LEAP) organised a scientific symposium on
visceral leishmaniasis (VL): “A step together in the right direction” at the centenary meeting
of the Royal Society of Tropical Medicine and Hygiene (RSTMH), in London. More than
120 scientists attended the meeting.

Click here to check the program
   
[ June 2007 ]
The Pan-Asian Network for Neglected Diseases (PAN4ND)
Annual Meeting - Shanghai

The PAN4ND Annual Meeting was held at Shanghai Institute Materia Medica,
from 4 to 6 
June 2007, and included three sessions: The Annual Meeting of the
Pan-Asian Screening Network; the Natural Product Working Group, and the
Natural Product Symposium.

Click here to read more
   
[ May 2007 ]
5th European Congress on Tropical Medicine & International Health
 (ECTMIH) - Amsterdam

DNDi presented on how Product Development Partnerships could deliver Innovation to 
patients
and on the sanofi-aventis/DNDi Partnership against malaria at the 5th ECTMIH from 24 to 28 May
in Amsterdam.

Click here to read the program
   
[ March 2007 ]
ASAQ Launch

Sanofi -aventis and DNDi launched ASAQ, the new fixed-dose combination of
artesunate (AS) and amodiaquine (AQ), which is now available in 21 countries
throughout sub-Saharan Africa (June 08). ASAQ, the first drug developed by DNDi,
is an innovative product to treat malaria that is adapted to the needs of patients of all ages,
simple to use, accessible as a non patented drug, and available at an affordable price.

Click here to read more
   
Press Contact
Media & Corporate
Communications

Eva van Beek
+41 22 906 92 50
+41 79 309 39 10
evanbeek@dndi.org


Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License